Rx · PZN 14036929, 14036987
IRINOTECAN Kabi 20 mg/ml 100mg concentrate for preparation of a solution for infusion
German trade nameIRINOTECAN Kabi 20 mg-ml 100mg Konzentrat zur Herstellung einer Infusionslösung
No observed availability
0.0out of 10
Storage temperature and transport temperature
Highest known
purchase price (B2B)
We deliver data-driven insights into pharmaceutical price levels and pricing structures across European markets, enabling Most Favoured Nation (MFN) assessments, international price benchmarking, and strategic market access analyses.
This figure is a rounded approximation. We are happy to advise you on your terms for IRINOTECAN Kabi 20 mg/ml 100mg concentrate for preparation of a solution for infusion.
Review purchasing termsIRINOTECAN Kabi 20 mg/ml 100mg concentrate for preparation of a solution for infusion contains the active ingredient Irinotecan and comes as Concentrate for solution for infusion. 2 pack sizes of this product are recorded. All packs reach a pharma availability index of 0.0 out of 10 over the past 30 days.
Pack sizes · 2 PZN
| PZN | Index 7 d | Index 30 d | Highest known purchase price |
|---|---|---|---|
| 14036929 | 0.0 | 0.0 | N/A |
| 14036987 | 0.0 | 0.0 | ~ €147 |
IRINOTECAN Kabi 20 mg/ml 100mg concentrate for preparation of a solution for infusion was not procurable through German pharmaceutical wholesale in the past 30 days. We help you identify sources of supply, import routes and alternative products.
Request a source of supply